Xeljanz Vs Enbrel Arthritis Medication

Arthritis refers to a group of illnesses that affect the musculoskeletal system. Your joints are the locations where your bones meet. Arthritis can cause your joints to become inflamed, stiff, red, and painful. Enbrel and Xeljanz are two effective arthritis medicines.

ENBREL is a medicine that affects your immune system. It can lower the ability of your immune system to fight infections. ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis.

Xeljanz (tofacitinib citrate), on the other hand, is a Janus kinase (JAK) inhibitor that is used to treat adults with moderate to severe active rheumatoid arthritis (RA) who have not responded to or cannot tolerate methotrexate.

Xeljanz (tofacitinib citrate) is a Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis.

. Xeljanz is an oral medication that works differently from the injectable medications and Enbrel to lessen joint pain and swelling caused by rheumatoid arthritis.
. Long-term safety studies have shown that Xeljanz may raise your risk of developing serious heart problems and cancer more than Enbrel.